Cover Image

A Non-interventional Study on Vismodegib for Basal Cell Carcinoma With A Treat-To-Target Regimen In Swedish Patients

Introduction: Real-life data on vismodegib in advanced basal cell carcinoma (aBCC) are limited. Optimal treatment duration is left to the discretion of the physician. Objectives: To assess the effectiveness, safety and treatment pattern for vismodegib in aBCC in clinical practice. Methods: In this m...

Full description

Saved in:

Bibliographic Details
Main Authors:	Niels Bendsöe (Author), John Paoli (Author), Karin Söderkvist (Author), Bertil Persson (Author), Christina Halldin (Author), Linda Ihrlund (Author), Maria Wolodarski (Author)
Format:	Book
Published:	Mattioli1885, 2023-04-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Investigational agents in metastatic basal cell carcinoma: focus on vismodegib
by: Batty N, et al.
Published: (2012)

Basal cell carcinoma: multimodal treatment and the role of neoadjuvant vismodegib
by: Pedro Carvalho Martins, et al.
Published: (2019)

Gorlin Syndrome: Sequential Digital Dermoscopy of Palpebral Basal Cell Carcinomas in a Patient Treated With Vismodegib
by: Luis Mena-Vergara, et al.
Published: (2022)

Granulation tissue masquerading as basal cell carcinoma after treatment with vismodegib
by: Jayson Miedema, MD, et al.
Published: (2018)

Vismodegib: A smoothened inhibitor for the treatment of advanced basal cell carcinoma
by: Suruchi Aditya, et al.
Published: (2013)

Neglected Basal Cell Carcinoma With Fatal Outcome
by: Jenna Pakka, et al.
Published: (2019)

Benefit-risk assessment of sonidegib and vismodegib in the treatment of locally advanced basal cell carcinoma
by: Antonio J García Ruiz, et al.
Published: (2022)

Metastatic same-site squamous cell carcinoma arising during vismodegib therapy for basal cell carcinoma
by: Raymond Zhao, BS, et al.
Published: (2022)

Spotlight on vismodegib in the treatment of basal cell carcinoma: an evidence-based review of its place in therapy
by: Apalla Z, et al.
Published: (2017)

Intracranial regression of an advanced basal cell carcinoma using sonidegib and itraconazole after failure with vismodegib
by: Jaeyoung Yoon, MD, PhD, et al.
Published: (2018)

Vismodegib dose reduction effective when combined with itraconazole for the treatment of advanced basal cell carcinoma
by: Jaeyoung Yoon, MD, PhD
Published: (2021)

Long-term safety, tolerability, and efficacy of vismodegib in two patients with metastatic basal cell carcinoma and basal cell nevus syndrome
by: Glen J. Weiss, et al.
Published: (2011)

9q22.3 Microdeletion Syndrome with Multiple Basal Cell Carcinomas Treated with Vismodegib: Three Key Messages in One Patient
by: Alice Kieny, et al.
Published: (2017)

SMO (SMOOTHENED TRANSMEMBRANE PROTEIN) INHIBITORS (VISMODEGIB) IN TREATMENT OF BASAL CELL CARCINOMA (BCC) OF OCULAR ADNEXA
by: Georgi Balchev, et al.
Published: (2020)

Vismodegib for treatment of periocular basal cell carcinoma - 6-year experience from a tertiary cancer center,
by: Catarina Xavier, et al.
Published: (2022)

Surgical Debulking Modifies Notch Signaling and May Improve Vismodegib Effectiveness for Locally Advanced Basal Cell Carcinoma
by: Natella Maglakelidze, et al.
Published: (2024)

[Translated article] Vismodegib and Sonidegib in Locally Advanced and Metastatic Basal Cell Carcinoma: Update on Hedgehog Pathway Inhibitors
by: J. Kurnia Wijaya, et al.
Published: (2022)

Results of Mohs' Micrographic Surgery of Periocular Basal Cell Carcinoma: The Swedish Experience
by: Kalliopi Erripi, et al.
Published: (2024)

Tolerance of sonidegib after intolerance of vismodegib-Experience in two patients with nevoid basal cell carcinoma syndrome (Gorlin syndrome)
by: Federico Venturi, et al.
Published: (2023)

Upfront Radiotherapy with Concurrent and Adjuvant Vismodegib Is Effective and Well-Tolerated in a Patient with Advanced, Multifocal Basal Cell Carcinoma
by: Abigail I. Franco, et al.
Published: (2018)

[Translated article] Multimodal Therapy With Vismodegib and Radiotherapy in the Treatment of Locally Advanced Basal Cell Carcinoma: A Series of 4 Cases
by: L. Pulido Prieto, et al.
Published: (2023)

Characterization of intractable diarrhea resulting from vismodegib treatment for basal cell nevus syndrome
by: Ashmi Patel, MS, et al.
Published: (2023)

Low-Dose Vismodegib as Maintenance Therapy After Locally Advanced Basal Cell Carcinoma Complete Remission: High Efficacy with Minimal Toxicity
by: Massimiliano Scalvenzi, et al.
Published: (2020)

Effectiveness, Safety and Utilization of Vismodegib for Locally Advanced Basal Cell Carcinoma Under Real-world Conditions: Non-interventional Cohort Study JONAS
by: Martin Kaatz, et al.
Published: (2022)

Same-site transdifferentiation of basal cell carcinoma to squamous cell carcinoma as a mechanism of vismodegib treatment resistance: Two cases requiring multimodal and multidisciplinary limb-sparing techniques
by: Brooke A. Burgess, MD, et al.
Published: (2024)

Vismodegib no Tratamento do Carcinoma Basocelular Avançado - Experiência de 3 Casos
by: Ana Gameiro, et al.
Published: (2016)

Rare bone toxicity associated with vismodegib
by: Valeria Ciciarelli, MD, et al.
Published: (2020)

Vismodegib y sonidegib en el carcinoma de células basales localmente avanzado y metastásico: actualización acerca de los inhibidores de la vía de Hedgehog
by: J. Kurnia Wijaya, et al.
Published: (2022)

Nonsurgical Options for the Treatment of Basal Cell Carcinoma
by: John Paoli, et al.
Published: (2019)

Real-Life Effectiveness of Vismodegib in Patients with Metastatic and Advanced Basal Cell Carcinoma: Characterization of Adverse Events and Assessment of Health-Related Quality of Life using the Dermatology Life Quality Index (DLQI) Test
by: Alessia Villani, et al.
Published: (2019)

Clinicopathological Factors Associated with Incomplete Excision of High-risk Basal Cell Carcinoma
by: Hannah Ceder, et al.
Published: (2021)

Medical marijuana for the treatment of vismodegib-related muscle spasm
by: Joyce T. Yuan, MD, et al.
Published: (2017)

Vismodegib in PAMAM-dendrimers for potential theragnosis in skin cancer
by: David E. Ybarra, et al.
Published: (2022)

A case of metastatic basal cell carcinoma treated with carboplatin and paclitaxel
by: Chryssoula Papageorgiou, et al.
Published: (2023)

Cryosurgery of Periocular Moderately Aggressive Basal Cell Carcinoma
by: Oscar Finskas, et al.
Published: (2020)

An interesting case of synchronous basal cell carcinoma of face successfully treated by surgery
by: Sucheta Pathania, et al.
Published: (2021)

Mohs Micrographic Surgery for Primary Versus Recurrent or Incompletely Excised Facial High-risk Basal Cell Carcinomas
by: Hannah Ceder, et al.
Published: (2021)

Metastatic Basal Cell Carcinoma: A Biological Continuum of Basal Cell Carcinoma?
by: Karaninder S. Mehta, et al.
Published: (2012)

Basal Cell Carcinoma
Published: (2012)

Cutaneous Superficial Basal Cell Carcinoma is a Basal Cell Carcinoma In Situ: Electron Microscopy of a Case Series of Basal Cell Carcinomas
by: Harsimran Kaur, et al.
Published: (2024)